- Report
- October 2025
- 196 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- October 2025
- 180 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- August 2025
- 185 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- November 2025
- 192 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- November 2025
- 184 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- November 2025
- 194 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- October 2025
- 193 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- October 2025
- 187 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- October 2025
- 185 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- October 2025
- 185 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- August 2025
- 188 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- July 2025
- 188 Pages
Global
From €3965EUR$4,500USD£3,483GBP
- Report
- March 2025
- 185 Pages
Global
From €3965EUR$4,500USD£3,483GBP
- Report
- February 2025
- 183 Pages
Global
From €3965EUR$4,500USD£3,483GBP
- Report
- January 2025
- 182 Pages
Global
From €3965EUR$4,500USD£3,483GBP
- Report
- January 2025
- 185 Pages
Global
From €3965EUR$4,500USD£3,483GBP
- Report
- December 2025
- 382 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- December 2025
- 178 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- December 2025
- 184 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- December 2025
- 341 Pages
Global
From €5155EUR$5,850USD£4,528GBP

Pharmacogenomics is a field of genomics that studies the relationship between an individual's genetic makeup and their response to drugs. It is used to develop personalized medicine, which is tailored to an individual's genetic profile. This field of genomics has the potential to revolutionize the way drugs are developed and prescribed, as it can help to identify which drugs are most effective for a particular patient. It can also help to reduce the risk of adverse drug reactions, as well as reduce the cost of drug development.
Pharmacogenomics is a rapidly growing field, with many companies investing in research and development. Examples of companies in the market include 23andMe, Genomics England, and Illumina. Show Less Read more